Redefining cell line development

Following the launch of Solentim’s new ICON™ instrument and dedicated STUDIUS™ software, the two of which complete the company’s cutting-edge ecosystem, we spoke with Dr Ian Taylor, Chief Business Officer, Solentim, to find out what this means for cell line development and the future of antibody therapeutics.

Read more Redefining cell line development

PRESS RELEASE: Solentim launch product enhancement for Cell Metric

New fluorescence option enables specific applications in cell line development Bournemouth, UK, Nov. 3, 2016/PRNewswire – Solentim, the developer of instrumentation for cell line development, announced today that it has launched a major enhancement for its world leading verification of clonality platform, the Cell Metric®. This enhancement, which enables two channel fluorescence on the Cell Metric …

Read more PRESS RELEASE: Solentim launch product enhancement for Cell Metric